These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4769128)

  • 21. Personality and the results of psychotropic drug treatment.
    Boleloucký Z; Vinar O; Tosovský J
    Act Nerv Super (Praha); 1972 Aug; 14(3):183-4. PubMed ID: 5052820
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals.
    Vinar O; Hamouz V; Bastecký J
    Act Nerv Super (Praha); 1968 Oct; 10(3):315-7. PubMed ID: 4883240
    [No Abstract]   [Full Text] [Related]  

  • 23. A controlled study of fluspirilene in chronic schizophrenia.
    Villeneuve A; Dogan K; Lachance R; Proulx C
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):819-27. PubMed ID: 4994687
    [No Abstract]   [Full Text] [Related]  

  • 24. The behavioral pharmacology of oxypertine.
    Claghorn J; Schoolar JC
    J Clin Pharmacol J New Drugs; 1970; 10(3):203-6. PubMed ID: 4910277
    [No Abstract]   [Full Text] [Related]  

  • 25. Penfluridol: once-a-week oral maintenance neuroleptic in the management of chronic schizophrenics.
    Kurland AA; Ota KY
    Psychopharmacol Bull; 1975 Jan; 11(1):12-4. PubMed ID: 1091943
    [No Abstract]   [Full Text] [Related]  

  • 26. A pilot study of AL-1021 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychopharmacologic characteristics of an indole compound--molindone.
    Claghorn JL
    Curr Ther Res Clin Exp; 1969 Aug; 11(8):524-7. PubMed ID: 4979704
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differential effects of neuroleptic drugs in chronic schizophrenics. A configuration analytical evaluation].
    Eckmann F; Gebert A; Lienert GA
    Arzneimittelforschung; 1974 Aug; 24(8):1135-8. PubMed ID: 4479475
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.
    Saletu B; Itil TM; Arat M; Akpinar S
    Int Pharmacopsychiatry; 1973; 8(4):193-207. PubMed ID: 4589638
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of methylperidol and trifluoperazine in the treatment of chronic, underactive schizophrenic patients.
    Jones IH; Davies J; Buckle R; Hanna WH; Pikler N
    Aust N Z J Psychiatry; 1970 Sep; 4(3):143-7. PubMed ID: 5286773
    [No Abstract]   [Full Text] [Related]  

  • 31. Antipsychotic properties of loxapine succinate.
    Gershon S; Hekimian LJ; Burdock EI; Kim SS
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract]   [Full Text] [Related]  

  • 32. Pimozide in the treatment of chronic schizophrenic patients.
    Chouinard G; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):598-603. PubMed ID: 4989691
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical evaluation of clopenthixol.
    Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
    Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
    Ngui PW; Teo SH
    Singapore Med J; 1971 Aug; 12(4):227-32. PubMed ID: 5129906
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical pharmacological trial of loxapine succinate.
    J Clin Pharmacol J New Drugs; 1970; 10(3):175-81. PubMed ID: 4910276
    [No Abstract]   [Full Text] [Related]  

  • 36. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 37. [Schizophrenic syndromes improving without neuroleptic drug treatment (author's transl)].
    Vinar O; Taussigová D
    Cesk Psychiatr; 1976 Jun; 72(3):176-81. PubMed ID: 786481
    [No Abstract]   [Full Text] [Related]  

  • 38. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 39. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

  • 40. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.